# CYP2F1

## Overview
CYP2F1 is a gene that encodes the enzyme cytochrome P450 family 2 subfamily F member 1, which is part of the cytochrome P450 superfamily of enzymes. These enzymes are monooxygenases that play a crucial role in the metabolism of various substances, including drugs and environmental chemicals. CYP2F1 is predominantly expressed in the human respiratory tract, particularly in lung tissue, where it is involved in the oxidative metabolism of pneumotoxicants such as naphthalene, styrene, and benzene (Carr2003Characterization; Tournel2007CYP2F1). The enzyme's activity in bioactivating these compounds into reactive intermediates underscores its significance in both detoxification processes and the potential for tissue damage, contributing to its role in organ-specific toxicity and individual susceptibility to environmental pollutants (Carr2003Characterization; Nhamburo1990The). Despite its involvement in metabolizing carcinogenic compounds, the clinical significance of CYP2F1 remains uncertain, with no direct association established between its genetic polymorphisms and lung cancer susceptibility (Tournel2007Molecular; Chong2021Global).

## Function
The CYP2F1 gene encodes a cytochrome P450 enzyme that is primarily expressed in the human respiratory tract, particularly in lung tissue (Carr2003Characterization; Tournel2007CYP2F1). This enzyme is involved in the metabolism of various pneumotoxicants, including naphthalene, 3-methylindole, styrene, and benzene, converting them into reactive intermediates that can be either detoxified or lead to tissue damage (Carr2003Characterization; Sheets2004Benzene; Tournel2007CYP2F1). CYP2F1 is capable of bioactivating naphthalene into a pneumotoxic intermediate and styrene into a carcinogenic epoxide, highlighting its role in the metabolic activation of procarcinogens (Carr2003Characterization; Tournel2007CYP2F1).

The enzyme is located in the endoplasmic reticulum of cells, where it participates in the oxidative metabolism of both endogenous and exogenous compounds (Nhamburo1990The). This activity is crucial for the detoxification processes, facilitating the excretion of potentially harmful substances and impacting cellular homeostasis (Nhamburo1990The). The expression of CYP2F1 is regulated by a lung-specific promoter region, which ensures its tissue-selective activity and contributes to the understanding of organ-specific toxicity and individual susceptibility to environmental pollutants (Carr2003Characterization; Tournel2007Molecular).

## Clinical Significance
The CYP2F1 gene is involved in the metabolism of various pneumotoxicants, which are compounds that can cause lung damage and have potential carcinogenic effects. Genetic polymorphisms in CYP2F1, such as the frameshift mutation c.14_15insC, result in a severely truncated and likely non-functional protein. This mutation is prevalent in certain populations, with frequencies varying significantly among ethnic groups, such as 26.1% in French and 51.6% in Gabonese populations (Tournel2007CYP2F1). Despite its role in metabolizing carcinogenic compounds, studies have not found a statistically significant association between CYP2F1 genetic polymorphisms and lung cancer susceptibility (Tournel2007Molecular).

The CYP2F1 enzyme is capable of bioactivating environmental toxicants like naphthalene and styrene, which are present in cigarette smoke and industrial by-products. These compounds can lead to organ-specific toxicity and potentially contribute to lung cancer susceptibility (Carr2003Characterization). Variations in the CYP2F1 gene may lead to differences in metabolic reactions, affecting individual susceptibility to lung carcinogenesis (Tournel2007CYP2F1). However, the clinical relevance of CYP2F1 remains unclear, and no specific diseases or conditions have been directly linked to its mutations or expression level alterations (Chong2021Global).

## Interactions



## References


[1. (Tournel2007CYP2F1) G. Tournel, C. Cauffiez, J. Leclerc, I. Billaut-Laden, D. Allorge, D. Chevalier, F. Migot-Nabias, A. Kenani, F. Broly, and J.-M. Lo-Guidice. Cyp2f1 genetic polymorphism: identification of interethnic variations. Xenobiotica, 37(12):1433–1438, December 2007. URL: http://dx.doi.org/10.1080/00498250701644403, doi:10.1080/00498250701644403. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/00498250701644403)

[2. (Carr2003Characterization) Brian A. Carr, Jie Wan, Ronald N. Hines, and Garold S. Yost. Characterization of the human lung cyp2f1 gene and identification of a novel lung-specific binding motif. Journal of Biological Chemistry, 278(18):15473–15483, May 2003. URL: http://dx.doi.org/10.1074/jbc.m300319200, doi:10.1074/jbc.m300319200. This article has 39 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m300319200)

[3. (Nhamburo1990The) Patson T. Nhamburo, Shioko Kimura, O. Wesley McBride, Christine A. Kozak, Harry V. Gelboin, and Frank J. Gonzalez. The human cyp2f gene subfamily: identification of a cdna encoding a new cytochrome p450, cdna-directed expression, and chromosome mapping. Biochemistry, 29(23):5491–5499, June 1990. URL: http://dx.doi.org/10.1021/bi00475a012, doi:10.1021/bi00475a012. This article has 71 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi00475a012)

[4. (Tournel2007Molecular) Gilles Tournel, Christelle Cauffiez, Ingrid Billaut-Laden, Delphine Allorge, Dany Chevalier, Fabien Bonnifet, Eric Mensier, Jean-Jacques Lafitte, Michel Lhermitte, Franck Broly, and Jean-Marc Lo-Guidice. Molecular analysis of the cyp2f1 gene: identification of a frequent non-functional allelic variant. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 617(1–2):79–89, April 2007. URL: http://dx.doi.org/10.1016/j.mrfmmm.2007.01.007, doi:10.1016/j.mrfmmm.2007.01.007. This article has 19 citations.](https://doi.org/10.1016/j.mrfmmm.2007.01.007)

[5. (Sheets2004Benzene) Patrick L. Sheets, Garold S. Yost, and Gary P. Carlson. Benzene metabolism in human lung cell lines beas‐2b and a549 and cells overexpressing cyp2f1. Journal of Biochemical and Molecular Toxicology, 18(2):92–99, January 2004. URL: http://dx.doi.org/10.1002/jbt.20010, doi:10.1002/jbt.20010. This article has 49 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jbt.20010)

[6. (Chong2021Global) Cheng‐Shoong Chong, Vachiranee Limviphuvadh, and Sebastian Maurer‐Stroh. Global spectrum of population‐specific common missense variation in cytochrome p450 pharmacogenes. Human Mutation, 42(9):1107–1123, June 2021. URL: http://dx.doi.org/10.1002/humu.24243, doi:10.1002/humu.24243. This article has 1 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.24243)